Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | GALR3 | O60755 | 1/20 | 0.55 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.55 |
| ▸ | ADK | P55263 | 12/20 | 0.53 |
| ▸ | PRMT5 | O14744 | 3/20 | 0.40 |
| ▸ | METTL3 | Q86U44 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23743992 | 0.90 | ADK (0.65) | NPC1GALR3S1PR4ALDH1A1MAPT | |
| SCHEMBL23949985 | 0.85 | ADK (0.49) | NPC1GALR3S1PR4ALDH1A1MAPT | |
| SCHEMBL23744000 | 0.82 | NPC1 (0.54) | NPC1GALR3S1PR4ALDH1A1MAPT | |
| SCHEMBL23950074 | 0.76 | ADK (0.59) | NPC1GALR3S1PR4ALDH1A1MAPT | |
| SCHEMBL23943037 | 0.76 | ADK (0.53) | ADKPRMT5METTL3 | |
| SCHEMBL23743999 | 0.75 | ADK (0.54) | NPC1GALR3S1PR4ALDH1A1MAPT | |
| SCHEMBL23745928 | 0.75 | ADK (0.54) | NPC1GALR3S1PR4ALDH1A1MAPT | |
| SCHEMBL24127868 | 0.75 | ADK (0.54) | NPC1GALR3S1PR4ALDH1A1MAPT | |
| SCHEMBL23396436 | 0.74 | AHCY (0.59) | ALDH1A1 | |
| SCHEMBL20794222 | 0.74 | AHCY (0.59) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021211757-A1 | METHOD FOR TREATING ARENAVIRIDAE INFECTIONS | OYAGEN, INC. (US) | 2021-10-21 | — | — | WO | disclosed |
| WO-2021158701-A1 | METHOD FOR TREATING CORONAVIRUS INFECTIONS | OYAGEN, INC. (US) | 2021-08-12 | — | — | WO | disclosed |